These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3803392)

  • 1. Differential reactivity of Glu-Gly-Arg-CH2Cl, a synthetic urokinase inhibitor, with single-chain and two-chain forms of urokinase-type plasminogen activator.
    Lijnen HR; Van Hoef B; Collen D
    Eur J Biochem; 1987 Jan; 162(2):351-6. PubMed ID: 3803392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of the enhanced intrinsic activity of single-chain urokinase-type plasminogen activator during ongoing fibrinolysis.
    Fleury V; Lijnen HR; Anglés-Cano E
    J Biol Chem; 1993 Sep; 268(25):18554-9. PubMed ID: 8103046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An enzyme-linked immunosorbent assay for urokinase-type plasminogen activator (u-PA) and mutants and chimeras containing the serine protease domain of u-PA.
    Declerck PJ; Van Keer L; Verstreken M; Collen D
    Thromb Haemost; 1992 Jan; 67(1):95-100. PubMed ID: 1377417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin.
    Lijnen HR; Van Hoef B; Collen D
    Eur J Biochem; 1987 Dec; 169(2):359-64. PubMed ID: 2961562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative kinetic analysis of the activation of human plasminogen by natural and recombinant single-chain urokinase-type plasminogen activator.
    Lijnen HR; Van Hoef B; Collen D
    Biochim Biophys Acta; 1986 Dec; 884(3):402-8. PubMed ID: 3778931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160.
    Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
    Eur J Biochem; 1988 Nov; 177(3):575-82. PubMed ID: 2973984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
    Barnathan ES; Kuo A; Rosenfeld L; Karikó K; Leski M; Robbiati F; Nolli ML; Henkin J; Cines DB
    J Biol Chem; 1990 Feb; 265(5):2865-72. PubMed ID: 2154462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nerve growth factor-gamma activates soluble and receptor-bound single chain urokinase-type plasminogen activator.
    Wolf BB; Vasudevan J; Henkin J; Gonias SL
    J Biol Chem; 1993 Aug; 268(22):16327-31. PubMed ID: 8393859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of single-chain urokinase-type plasminogen activator by thrombin in human subjects.
    Braat EA; Levi M; Bos R; Haverkate F; Lassen MR; de Maat MP; Rijken DC
    J Lab Clin Med; 1999 Aug; 134(2):161-7. PubMed ID: 10444030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inactivation of single-chain urokinase-type plasminogen activator by thrombin on cultured human endothelial cells.
    Braat EA; Collen A; Jie AF; Grimbergen JM; Rijken DC
    Biochim Biophys Acta; 2000 Sep; 1497(3):351-8. PubMed ID: 10996659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The susceptibility of urokinase to affinity labeling by peptides of arginine chloromethyl ketone.
    Kettner C; Shaw E
    Biochim Biophys Acta; 1979 Jul; 569(1):31-40. PubMed ID: 465506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition in purified systems and in human plasma of chimaeric plasminogen activators consisting of the NH2-terminal region of tissue-type plasminogen activator and the COOH-terminal region of urokinase-type plasminogen activator.
    Lijnen HR; Nelles L; Van Hoef B; De Cock F; Collen D
    Thromb Haemost; 1988 Oct; 60(2):247-50. PubMed ID: 3146141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of plasminogen activation by glycosylphosphatidylinositol-anchored urokinase.
    Lee SW; Ellis V; Dichek DA
    J Biol Chem; 1994 Jan; 269(4):2411-8. PubMed ID: 8300567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
    Ugwu F; Van Hoef B; Bini A; Collen D; Lijnen HR
    Biochemistry; 1998 May; 37(20):7231-6. PubMed ID: 9585535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urokinase-mediated fibrinolysis in the synovial fluid of rheumatoid arthritis patients may be affected by the inactivation of single chain urokinase type plasminogen activator by thrombin.
    Braat EA; Jie AF; Ronday HK; Beekman B; Rijken DC
    Ann Rheum Dis; 2000 Apr; 59(4):315-8. PubMed ID: 10733483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Half-life of single-chain urokinase-type plasminogen activator (scu-PA) and two-chain urokinase-type plasminogen activator (tcu-PA) in patients with acute myocardial infarction.
    Köhler M; Sen S; Miyashita C; Hermes R; Pindur G; Heiden M; Berg G; Mörsdorf S; Leipnitz G; Zeppezauer M
    Thromb Res; 1991 Apr; 62(1-2):75-81. PubMed ID: 1906642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor-binding protein activates soluble and receptor-bound single chain urokinase-type plasminogen activator.
    Wolf BB; Brown MD
    FEBS Lett; 1995 Dec; 376(3):177-80. PubMed ID: 7498536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA).
    Nelles L; Lijnen HR; Van Nuffelen A; Demarsin E; Collen D
    Thromb Haemost; 1990 Aug; 64(1):53-60. PubMed ID: 2148847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding.
    Jiao J; Yu M; Ru B
    Biochim Biophys Acta; 2001 Apr; 1546(2):399-405. PubMed ID: 11295444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inactivation of single-chain urokinase-type plasminogen activator by thrombin in a plasma milieu: effect of thrombomodulin.
    Braat EA; Los P; Rijken DC
    Blood Coagul Fibrinolysis; 1998 Jul; 9(5):419-27. PubMed ID: 9712290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.